Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

40%

2 trials in Phase 3/4

Results Transparency

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

2(40.0%)

Phase 4

2(40.0%)

Phase 2

1(20.0%)

5Total

N/A(2)

Phase 4(2)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT07267624Not ApplicableNot Yet Recruiting

EARLY Antibiotics aDAptation in Severe Pneumonia(The EARLY ADAPT Study)

Role: collaborator

NCT05261516Phase 4Recruiting

Interaction of Volatile Anesthetics With Magnesium

Role: collaborator

NCT02001922Not ApplicableCompleted

Soins intégrés BPCO (Broncho-pneumopathie Chronique Obstructive) en Valais - Mieux Vivre Avec ma BPCO (COPD Integrated Care Program Valais - Living Well With COPD)

Role: lead

NCT01670474Phase 4Unknown

Prolonged Hemodialysis Catheter Survival With Copolymer Coating and Rt-PA

Role: lead

NCT01103076Phase 2Unknown

Effects of High Cut-off (HCO) Hemodialysis on Central Memory CD4+ T and Treg Cells in Patients With End-stage Kidney Disease

Role: lead

All 5 trials loaded